Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice.

BACKGROUND: Human metapneumovirus (HMPV) causes respiratory tract infections among infant, elderly, and immunocompromised patients, with significant mortality. Currently no licensed vaccines or therapeutic agents of HMPV exist.

METHODS: HMPV virus-like particle (VLP) was constructed by co-expressing fusion protein of HMPV and matrix 1 protein of influenza virus using the baculovirus expression. Mice were immunized with VLP with or without aluminium hydroxide (alum) adjuvant by intramuscular route respectively. Sera were determined for titers of IgG and neutralizing antibody. Splenic lymphocytes were determined by IFN-γ and IL-4 ELISPOT. Mice were challenged with HMPV, and protective efficacy was evaluated.

RESULTS: We generated HMPV VLP in baculovirus expression system. After three times immunization, IgG antibody titers induced by VLP formulated with or without alum adjuvant group were 273,066±100,331 and 136,533±47,269 respectively, there was no difference (p˃0.05); the neutralizing antibody titers vaccinated with VLP plus with alum adjuvant (266±92) were higher than those of the VLP alone group (106±37). For IFN-γ, mice vaccinated with VLP with or without alum adjuvant are 151±36.4 and 77.0±17.1SFC/106 respectively, there was difference (p=0.03); For IL-4, they are 261.3±38.7 versus 125.67±29.78SFC/106 respectively, the difference was significant (p=0.009). After challenge, in pathological analysis, the overall lesion scores in the VLP plus with and without alum adjuvant were 3.25 and 5.6 respectively, those of control group is 8. For immunohistochemical analyses, the average optical density of the lungs in the VLP immunized group containing adjuvant (9.07±1.74) was lower than that in the VLP group without adjuvant (12.83±2.31, p=0.14).

CONCLUSIONS: This is the first study to demonstrate that HMPV VLP was successfully prepared in the baculovirus expression system. HMPV VLP could induce specific humoral and cellular immune responses as well as protective efficacy, and aluminium hydroxide may be an effective adjuvant in mice.